Tango Therapeutics (TNGX) Other Non-Current Assets (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Other Non-Current Assets of $293000.0 for Q1 2026, down 88.73% year-over-year from $2.6 million in Q1 2025, and down 3.3% quarter-over-quarter from $303000.0 in Q4 2025.
Tango Therapeutics (TNGX) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Tango Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $293000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 88.73% year-over-year to $293000.0; the TTM figure through Mar 2026 stood at $293000.0 (down 88.73% YoY), while the FY2025 annual figure was $303000.0, down 88.35% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $293000.0, down from $303000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $4.0 million in Q1 2022, with the low at $290000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $2.6 million (2024), against an average of $2.7 million.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 73.91% in 2022, then sank 88.85% in 2025.
- Tango Therapeutics' Other Non-Current Assets stood at $4.0 million in 2022, then fell by 15.0% to $3.4 million in 2023, then decreased by 23.53% to $2.6 million in 2024, then slumped by 88.35% to $303000.0 in 2025, then dropped by 3.3% to $293000.0 in 2026.
- Business Quant data shows TNGX's Other Non-Current Assets at $293000.0 in Q1 2026, $303000.0 in Q4 2025, and $290000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14 Mn |
| Mar 31, 2026 | 293,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.30 Mn |